NCT06145321View on ClinicalTrials.gov

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2024

Conditions
Pediatric CancerNeutropeniaLenograstimFilgrastimG-CSF
Interventions
DEVICE

G-CSF administration (bolus injection versus intravenous infusion)

Route of administration: intravenous infusion (with a 5 hours infusion period) or intravenous bolus (with an infusion period of less than one minute)

DRUG

G-CSF administration (bolus injection versus intravenous infusion)

Route of administration: intravenous infusion (with a 5 hours infusion period) or intravenous bolus (with an infusion period of less than one minute)

Trial Locations (1)

333005

Chang Gung Children Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT06145321 - Continuous Versus Bolus Administration of G-CSF in Children With Cancer | Biotech Hunter | Biotech Hunter